443956-21-6

Basic information

• Product Name: methyl 6-amino-3,5-dibromopicolinate
• Synonyms: Methyl 6-aMino-3,5-dibroMopyridine-2-carboxylate;6-Amino-3,5-dibromopyridine-2-carboxylic acid methyl ester;methyl 6-amino-3,5-dibromopicolinate
• CAS NO: 443956-21-6
• Molecular Formula: C7H6Br2N2O2
• Molecular Weight: 310
• Mol File: 443956-21-6.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Density: 1.997
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: methyl 6-amino-3,5-dibromopicolinate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 6-amino-3,5-dibromopicolinate(443956-21-6)
• EPA Substance Registry System: methyl 6-amino-3,5-dibromopicolinate(443956-21-6)

Safety Data

• Hazardous Substances Data: 443956-21-6(Hazardous Substances Data)

Usage

Description

Methyl 6-amino-3,5-dibromopicolinate is an organic compound that serves as a key intermediate in the synthesis of various pharmaceutical compounds. It is characterized by the presence of an amino group, two bromine atoms, and a methyl ester group attached to a picolinic acid structure.

Uses

Used in Pharmaceutical Industry:
Methyl 6-amino-3,5-dibromopicolinate is used as a reagent in the synthesis of imidazopyridines, which are Syk inhibitors. These Syk inhibitors have potential applications in the treatment of inflammatory and autoimmune diseases by modulating the activity of the spleen tyrosine kinase enzyme.
Used in Antibacterial Agents:
Methyl 6-amino-3,5-dibromopicolinate is also used as a reagent in the synthesis of quinoline, quinoxaline, and naphthyridine derivatives. These compounds exhibit antibacterial properties and can be used in the development of new antibiotics to combat drug-resistant bacterial infections.

Upstream product

• 178876-83-0 methyl 6-amino-3-bromo-pyridine-2-carboxylate 
• 23628-31-1 6-aminopicolinic acid 
• 36052-26-3 methyl 6-aminopyridine-2-carboxylate 

Relevant articles and documents

ANTI PARASITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME

The present invention relates to novel dihydroazole of formula (I) and salts thereof: Wherein R1, A1, A2, G, X and Y are as defined in the description, compositions thereof, processes for their preparation and their uses t

NITROGEN-CONTAINING BICYCLIC HETEROCYCLES FOR USE AS ANTIBACTERIALS

Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives hereof useful in methods of treatment of bacterial infections in mammals, particularly man.